Rocket Pharmaceuticals Inc [NASDAQ: RCKT] stock went on an upward path that rose over 5017941% on Wednesday, amounting to a one-week price decrease of less than -2.57%.
Over the last 12 months, RCKT stock dropped by -78.92%. The one-year Rocket Pharmaceuticals Inc stock forecast points to a potential downside of -56367563.34. The average equity rating for RCKT stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $285.51 million, with 106.75 million shares outstanding and 99.77 million shares in the current float. Compared to the average trading volume of 5.09M shares, RCKT stock reached a trading volume of 5017941 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Rocket Pharmaceuticals Inc [RCKT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RCKT shares is $9.03 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RCKT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Evercore ISI have made an estimate for Rocket Pharmaceuticals Inc shares, keeping their opinion on the stock as In-line, with their previous recommendation back on May 30, 2025. The new note on the price target was released on May 28, 2025, representing the official price target for Rocket Pharmaceuticals Inc stock. Previously, the target price had yet another raise to $8, while Leerink Partners analysts kept a Market Perform rating on RCKT stock.
The Price to Book ratio for the last quarter was 0.69, with the Price to Cash per share for the same quarter was set at 2.95.
RCKT Stock Performance Analysis:
Rocket Pharmaceuticals Inc [RCKT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.57. With this latest performance, RCKT shares dropped by -57.74% in over the last four-week period, additionally sinking by -76.65% over the last 6 months – not to mention a drop of -78.92% in the past year of trading.
Insight into Rocket Pharmaceuticals Inc Fundamentals:
Return on Equity for this stock declined to -53.17%, with Return on Assets sitting at -53.17%.
RCKT Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RCKT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Rocket Pharmaceuticals Inc go to 21.48%.
Rocket Pharmaceuticals Inc [RCKT] Institutonal Ownership Details
There are presently around $93.45%, or 96.07% of RCKT stock, in the hands of institutional investors. The top three institutional holders of RCKT stocks are: RTW INVESTMENTS, LP with ownership of 17.69 million shares, which is approximately 18.8677%. WELLINGTON MANAGEMENT GROUP LLP, holding 9.16 million shares of the stock with an approximate value of $$197.12 million in RCKT stocks shares; and WELLINGTON MANAGEMENT GROUP LLP, currently with $$133.33 million in RCKT stock with ownership which is approximately 6.6057%.
